SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-019599
Filing Date
2019-07-15
Accepted
2019-07-15 16:05:36
Documents
1
Period of Report
2019-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3770
  Complete submission text file 0000899243-19-019599.txt   5222
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 4023 HERZLIYA PITUACH L3 4614001
Business Address
Chimovits Erez (Reporting) CIK: 0001706399 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36620 | Film No.: 19955257